Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Rifampin (P-RIF) Trial for Personalized Dosing in Active Tuberculosis Disease

NCT06318416 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT06318416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06318416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Rifampin (P-RIF) Trial for Personalized Dosing in Active Tuberculosis Disease
Lead sponsor
University of Virginia
Phase
Phase 1
Overall status
Recruiting
Start date
October 1, 2025
Completion date
June 1, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis